FY25 revenue surged 27%, fueled by B2B growth and new tools. Merchant solutions segment contributed 74% of revenue. See more ...

PennantPark Investment (PNNT) faces challenges with declining NII and NAV, unsustainable dividends, and price drops. See more ...

Discover key takeaways from Talphera's Q1 2025 Earnings Call! Learn about FDA protocol changes, financial updates, and progress on the NEPHRO CRRT study.

Timing the market is risky and shorting the ProShares UltraPro Short QQQ ETF (SQQQ) might not be ideal despite fundamental ...